A phase I open-label study of selinexor with paclitaxel and carboplatin in patients with advanced ovarian or endometrial cancers

Maria M. Rubinstein, Rachel N. Grisham, Karen A. Cadoo, Chrisann Kyi, William P. Tew, Claire F. Friedman, Roisin E. O’Cearbhaill, Dmitriy Zamarin, Qin Zhou, Alexia Iasonos, Ines Nikolovski, Hongmei Xu, Krysten Soldan, Imogen Caird, Madhuri Martin, Joyce Guillen, Khalil T. Eid, Carol Aghajanian, Vicky Makker